85
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Clinical experience with ezetimibe/simvastatin in a Mediterranean population

, , , , &
Pages 2571-2576 | Accepted 08 Jul 2009, Published online: 09 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis & Dimitri P. Mikhailidis. (2014) Reaching hypertriglyceridemia goals. Current Medical Research and Opinion 30:3, pages 391-393.
Read now
Dimitri P. Mikhailidis, Richard W. Lawson, Anna-Louise McCormick, Gillian C. Sibbring, Andrew M. Tershakovec, Glenn M. Davies & Kaan Tunceli. (2011) The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients. Current Medical Research and Opinion 27:10, pages 1961-1961.
Read now
Niki Katsiki, Vasilis G. Athyros, Asterios Karagiannis & Dimitri P. Mikhailidis. (2011) Ezetimibe and low density lipoprotein subfractions: an ongoing debate. Current Medical Research and Opinion 27:3, pages 693-695.
Read now
Matilda Florentin, Evangelos N. Liberopoulos, Elisavet Moutzouri, Christos V. Rizos, Alexandros D. Tselepis & Moses S. Elisaf. (2011) The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia. Current Medical Research and Opinion 27:3, pages 685-692.
Read now
Nkechinyere Ijioma & Jennifer G Robinson. (2011) Lipid-lowering effects of ezetimibe and simvastatin in combination. Expert Review of Cardiovascular Therapy 9:2, pages 131-145.
Read now
Anna Gluba, Jacek Rysz & Maciej Banach. (2010) Statins in patients with chronic kidney disease: why, who and when?. Expert Opinion on Pharmacotherapy 11:16, pages 2665-2674.
Read now
Maria Sarigianni, Niki Katsiki & Dimitri P Mikhailidis. (2010) Ezetimibe in diabetes: more than cholesterol lowering?. Current Medical Research and Opinion 26:10, pages 2517-2520.
Read now

Articles from other publishers (15)

Niki Katsiki & Dimitri P Mikhailidis. (2018) Lipids: a personal view of the past decade. Hormones 17:4, pages 461-478.
Crossref
Vasilios G. Athyros, Niki Katsiki & Dimitri P. Mikhailidis. (2016) Statins, renal function and homocysteine. Pharmacological Reports 68:5, pages 1093.
Crossref
Niki Katsiki, Vasilios G. Athyros & Dimitris P. Mikhailidis. (2016) More news from IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial). Hormones 15:1, pages 5-7.
Crossref
Fotios Barkas, Evangelos N. Liberopoulos, Michael S. Kostapanos, George Liamis, Dimitrios Tziallas & Moses Elisaf. (2014) Lipid Target Achievement Among Patients With Very High and High Cardiovascular Risk in a Lipid Clinic. Angiology 66:4, pages 346-353.
Crossref
George N. Kouvelos, Eleni M. Arnaoutoglou, Haralampos J. Milionis, Vaia D. Raikou, Nektario Papa & Miltiadis I. Matsagkas. (2014) The Effect of Adding Ezetimibe to Rosuvastatin on Renal Function in Patients Undergoing Elective Vascular Surgery. Angiology 66:2, pages 128-135.
Crossref
Ioanna Xanthopoulou, Periklis Davlouros, Simos Siahos, Angelos Perperis, Evangelia Zaharioglou & Dimitrios Alexopoulos. (2013) First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients. Lipids in Health and Disease 12:1.
Crossref
Mariëtte Y.M. van der Wulp, Henkjan J. Verkade & Albert K. Groen. (2013) Regulation of cholesterol homeostasis. Molecular and Cellular Endocrinology 368:1-2, pages 1-16.
Crossref
Elisavet Moutzouri, Evangelos N. Liberopoulos, Matilda Florentin, George Liamis & Moses S. Elisaf. (2012) Effects of Statin Monotherapy Versus Statin Plus Ezetimibe Combination on Serum Uric Acid Levels. Journal of Cardiovascular Pharmacology and Therapeutics 18:1, pages 13-18.
Crossref
Michael S. Kostapanos, Moses S. Elisaf & Dimitri P. Mikhailidis. (2012) Effect of Atorvastatin Monotherapy and Low-Dose Atorvastatin/Ezetimibe Combination on Fasting and Postprandial Triglycerides in Combined Hyperlipidemia. Journal of Cardiovascular Pharmacology and Therapeutics 17:4, pages 427-427.
Crossref
Michael S Kostapanos, Dimitri P Mikhailidis & Moses S Elisaf. (2012) Adding ezetimibe to statin treatment: is LDL-C lowering the only benefit?. Future Cardiology 8:6, pages 813-817.
Crossref
Evangelos Liberopoulos, Fotini Vlasserou, Zoe Mitrogianni, Ioannis Papageorgantas & Moses Elisaf. (2011) Prevalence and Risk Distribution of Residual Dyslipidemia in Statin-Treated Patients in Greece. Angiology 63:3, pages 184-193.
Crossref
Yusaku Mori & Tsutomu Hirano. (2012) Ezetimibe alone or in combination with pitavastatin prevents kidney dysfunction in 5/6 nephrectomized rats fed high-cholesterol. Metabolism 61:3, pages 379-388.
Crossref
Kosmas I. ParaskevasAlkistis Pantopoulou, Ioannis S. Vlachos, George Agrogiannis, Dimitrios G. Iliopoulos, Gabriel Karatzas, Dimitrios Tzivras, Dimitri P. Mikhailidis & Despina N. Perrea. (2011) Comparison of Fibrate, Ezetimibe, Low- and High-Dose Statin Therapy for the Dyslipidemia of the Metabolic Syndrome in a Mouse Model. Angiology 62:2, pages 144-154.
Crossref
Piero RuggenentiAnnalisa PernaGiuseppe Remuzzi. (2010) Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A Prospective Randomized Double-Blind Clinical Trial. Diabetes Care 33:10, pages e133-e133.
Crossref
Maria SarigianniNiki KatsikiDimitri P. Mikhailidis. (2010) Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A Prospective Randomized Double-Blind Clinical Trial. Diabetes Care 33:10, pages e132-e132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.